MetLife (MET) Tops Q2 EPS by 7c
Tweet
Share
E-mail
Get Alerts MET Hot Sheet
Price: $97.62 -1.62%
EPS Growth %: +9.4%
Financial Fact:
Total expenses: 17.18B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +9.4%
Financial Fact:
Total expenses: 17.18B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
MetLife (NYSE: MET) reported Q2 EPS of $2.43, $0.07 better than the analyst estimate of $2.36. Revenue for the quarter came in at $19.15 billion versus the consensus estimate of $19.68 billion.
For earnings history and earnings-related data on MetLife (MET) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Starts Shake Shack (SHAK) at Outperform
- UBS Upgrades EchoStar Corporation (ECHO) to Buy
- Barclays Downgrades Zealand Pharma A/S (ZEAL:DC) (ZEAL) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
